GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,565,000 | -0.8% | 37,665 | -53.5% | 0.01% | 0.0% |
| Q2 2022 | $2,586,000 | -7.8% | 80,948 | 0.0% | 0.01% | +11.1% |
| Q1 2022 | $2,804,000 | +7.1% | 80,948 | -9.5% | 0.01% | +12.5% |
| Q4 2021 | $2,617,000 | +0.8% | 89,418 | -12.2% | 0.01% | 0.0% |
| Q3 2021 | $2,595,000 | +11.1% | 101,850 | +52.8% | 0.01% | 0.0% |
| Q2 2021 | $2,335,000 | +15.8% | 66,675 | +34.8% | 0.01% | +14.3% |
| Q1 2021 | $2,016,000 | +23.1% | 49,467 | +30.8% | 0.01% | +16.7% |
| Q4 2020 | $1,638,000 | -26.7% | 37,825 | -6.7% | 0.01% | -33.3% |
| Q3 2020 | $2,235,000 | -10.7% | 40,535 | +2.2% | 0.01% | -10.0% |
| Q2 2020 | $2,504,000 | +11.9% | 39,666 | -9.4% | 0.01% | -9.1% |
| Q1 2020 | $2,238,000 | -35.7% | 43,800 | 0.0% | 0.01% | -15.4% |
| Q4 2019 | $3,482,000 | +63.9% | 43,800 | 0.0% | 0.01% | +62.5% |
| Q3 2019 | $2,125,000 | – | 43,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |